- Home
- TSHA vs MBWM Comparison
TSHA vs MBWM Comparison
Compare TSHA & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- MBWM
- Stock Information
- Founded
- TSHA 2019
- MBWM 1997
- Country
- TSHA United States
- MBWM United States
- Employees
- TSHA N/A
- MBWM N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- MBWM Major Banks
- Sector
- TSHA Health Care
- MBWM Finance
- Exchange
- TSHA Nasdaq
- MBWM Nasdaq
- Market Cap
- TSHA 728.4M
- MBWM 726.9M
- IPO Year
- TSHA 2020
- MBWM 1997
- Fundamental
- Price
- TSHA $2.32
- MBWM $47.81
- Analyst Decision
- TSHA Strong Buy
- MBWM Buy
- Analyst Count
- TSHA 5
- MBWM 2
- Target Price
- TSHA $8.20
- MBWM $52.25
- AVG Volume (30 Days)
- TSHA 3.7M
- MBWM 77.3K
- Earning Date
- TSHA 08-11-2025
- MBWM 07-22-2025
- Dividend Yield
- TSHA N/A
- MBWM 3.19%
- EPS Growth
- TSHA N/A
- MBWM N/A
- EPS
- TSHA N/A
- MBWM 4.80
- Revenue
- TSHA $7,224,000.00
- MBWM $222,296,000.00
- Revenue This Year
- TSHA N/A
- MBWM $8.87
- Revenue Next Year
- TSHA N/A
- MBWM $3.71
- P/E Ratio
- TSHA N/A
- MBWM $9.67
- Revenue Growth
- TSHA N/A
- MBWM 0.96
- 52 Week Low
- TSHA $1.05
- MBWM $37.76
- 52 Week High
- TSHA $3.31
- MBWM $52.98
- Technical
- Relative Strength Index (RSI)
- TSHA 41.03
- MBWM 70.78
- Support Level
- TSHA $2.29
- MBWM $44.85
- Resistance Level
- TSHA $2.48
- MBWM $46.08
- Average True Range (ATR)
- TSHA 0.17
- MBWM 1.14
- MACD
- TSHA -0.05
- MBWM 0.33
- Stochastic Oscillator
- TSHA 9.21
- MBWM 88.81
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.